BAXBaxter International

Health care · Medical Instruments · NYSE

Employees: 37,500
Headquarters: Deerfield, IL
CEO: Andrew P. Hider
Next results: around Feb 11, 2027

What BAX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans adopted or ended

Insider	What	Date	Shares	Runs to	Reported in
Jeanne Mason Chief Human Resources Officer	Adopted 10b5-1 plan	Sep 6, 2023	up to 218,731	544 days	10-Q Nov 2, 2023
The company's description On September 6, 2023, Jeanne Mason, our Chief Human Resources Officer, entered into a modification to her existing trading plan for the sale of certain shares of our common stock in connection with the exercise of expiring stock options, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. As modified, the plan terminates on March 3, 2025. The aggregate number of shares to be sold under the modified plan is 218,731 shares.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 27, 2023.

Form 144 notices of planned sales

Filed	Seller	Shares	Value	Shares came from	10b5-1 plan	Form 4 sales after
May 18, 2026	STEPHEN N. OESTERLE REV TRUST Former Affiliate	36,347	$645,236	Open Market Purchase	none given	none found

From the Form 144 XML filed with the SEC, since May 18, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Work on BAX in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/BAX/export.csv") into a cell.